Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Vasculitis × Niclosamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Vasculitis 1 Neoplasms 1 Lupus Erythematosus, Systemic 1 Leukemia, Myeloid, Acute 1 Glomerulonephritis 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 COVID-19 1 Adenomatous Polyposis Coli 1

Interventions

Etanercept 2 sotrovimab 1 ciclesonide 1 Tomography, X-Ray Computed 1 Tomography, Emission-Computed 1 Positron-Emission Tomography 1 Niclosamide 1 Magnetic Resonance Imaging 1 Infliximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04870333 2025-06-20

PROTECT-V

Cambridge University Hospitals NHS Foundation Trust

Phase 2/3 Completed

COVID-19, Glomerulonephritis, Lupus Erythematosus, Systemic, Neoplasms, Vasculitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡